Advances in Urology

Advances in Urology / 2013 / Article

Clinical Study | Open Access

Volume 2013 |Article ID 765023 | https://doi.org/10.1155/2013/765023

Ayhan Karaköse, Mehmet Bilgehan Yuksel, Özgü Aydoğdu, Aziz Ahmad Hamidi, "Epididymoorchitis as the First Finding in Patients with Brucellosis", Advances in Urology, vol. 2013, Article ID 765023, 4 pages, 2013. https://doi.org/10.1155/2013/765023

Epididymoorchitis as the First Finding in Patients with Brucellosis

Academic Editor: Maxwell V. Meng
Received11 Jun 2013
Accepted15 Oct 2013
Published26 Dec 2013

Abstract

Purpose. Acute scrotal pain as the first symptom of brucellosis is rarely observed. We aimed to evaluate the data of male patients with brucellosis and epididymoorchitis as the initial diagnosis. Material and Methods. The data of seven patients presented with testicular pain, hyperemia, swelling, and increased fever were reviewed. Concomitant focal diseases as well as clinical, laboratory, and radiological findings were retrospectively evaluated. Results. The mean age of the patients was 22.28 ± 7.78 (16–35) years. All patients presented with scrotal pain, swelling, and increased sweating. Additional findings included fever, asthenia, arthralgia, dysuria, shiver and rash, weight loss, and vomiting in 6, 5, 4, 4, 3, 2, and 1 patient, respectively. In all of 7 patients, the agglutination tests of Rose-Bengal and Wright were positive. Coombs test was positive only in 3 patients. The patients underwent antibiotic and conservative treatment. No relapse was observed following the treatment. Conclusion. In endemic regions, epididymoorchitis caused by brucellosis should be considered in the differential diagnosis of patients presenting with acute scrotal pain. Clinical and serological findings are sufficient for the diagnosis. Conservative management combined with antibiotic therapy is adequate for managing brucellar epididymoorchitis.

1. Introduction

Brucellosis, which is also called Mediterranean or Malta fever, is an endemic enzootic disease and can involve various organ systems. Brucellosis constitutes a major health and economic problem in many parts of the world, encompassing the Mediterranean countries and Middle East [1, 2]. Epididymoorchitis is a focal form of human brucellosis with an incidence of 2–20% in patients with brucellosis [3, 4]. Brucella species cause granulomatous orchitis usually presenting as an acute or chronic unilateral swelling of the testis. Epididymoorchitis can be seen as a subsequent part of systemic disease after the previous diagnosis of Brucellosis. However, although the occurrence of Brucellar epididymoorchitis (BEO) as the presenting finding is an extremely rare manifestation of Brucellosis, patients can rarely apply to the clinicians with acute scrotum as an initial finding. Thus, BEO must be considered in the differential diagnosis of acute scrotum in endemic regions [59]. In the recent study, we aimed to describe the data of 7 patients who had no previous diagnosis of Brucellosis and were with BEO as a single, primary manifestation of the disease in endemic region of Mus, Turkey, and to present the importance of considering the BEO in the cases of acute scrotum in endemic regions of Brucellosis.

2. Materials and Methods

The data of 7 patients who had no previous diagnosis of Brucellosis and applied to our out-patient clinic with only testicular pain, hyperemia, swelling, and increased fever as an acute scrotum case between February 2011 and February 2012 were reviewed. Haemogram, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), urine analysis, and scrotal power duplex ultrasound scan (US) findings were retrospectively evaluated. Initially, all patients were diagnosed as nonspecific orchitis and treated with antibiotics and analgesic. In the following period, the patients consulted the infectious disease clinic since the complaints were not improved. All patients were hospitalized and followed in the infectious disease clinic to investigate the potential etiologic factors of antibiotic resistant nonspecific epididymoorchitis. Haemogram, urine culture, CRP, ESR, ALT, blood culture, Rose-Bengal test, Wright agglutination test, and Coombs test were performed in all patients. In addition, scrotal color Doppler US and MRI were performed for the differential diagnosis of testicular masses.

3. Results

The 7 patients had no previous diagnosis of brucellosis when they applied to our outpatient clinic. The mean age of the patients with a diagnosis of BEO was (16–35) years. Totally 28 male patients have been hospitalized for brucellosis in infectious disease clinic between February 2011 and February 2012 (mean age; (16–70) years). BEO rate in all brucellosis cases was calculated as 25%. All BEO cases presented with acute scrotal pain, swelling, and increased sweating. Additional findings included fever, asthenia, arthralgia, dysuria, shiver and rash, weight loss, and vomiting (Table 1).


Finding %

Scrotal pain and swelling7100
Fever (temperature, ≥38°C)685.71
Sweating7100
Asthenia571.42
Arthralgia457.14
Shiver342.85
Dysuria457.14
Weight loss228.57
Rash342.85
Vomiting114.28

Coexisting focal disease included osteoarticular involvement, spondylitis, sacroiliitis, peripheral arthritis, and hepatitis in 4, 3, 2, 2, and 1 patients, respectively (Table 2).


Focal disease %

Osteoarticular involvement457.14
Sacroiliitis228.57
Hepatitis114.28
Spondylitis342.85
Peripheral arthritis228.57

Laboratory investigations showed that all of BEO patients had positive Rose-Bengal and Wright agglutination tests. Coombs test was positive in 3 of 7 patients. Other abnormal laboratory findings included CRP > 5 mg/dL (6 patients), ESR > 20 mm/h (5 patients), WBC > 10.500 WBCs/mm3 (3 patients), ALT > 40 IU/L (3 patients), ALP > 150 IU/L (1 patient), and PLT < 150.000 Platelets/mm3 (1 patient) (Table 3). Blood and urine cultures were clear in all patients.


%

Positive Rose-Bengal test7100
Positive Wright agglutination (≥1 : 160)7100
Positive Coombs test342.85
CRP > 5 mg/dL (mean CRP 14.99 ± 10.70 (2.17–32.50) mg/dL)685.71
ESR > 20 mm/h (mean ESR 24.57 ± 21.76 (2–58) mm/h)571.42
WBCs/mm3 > 10.500342.85
Platelets/mm3 < 150.000114.28
ALP > 150 IU/L114.28
ALT > 40 IU/L342.85

The scrotal color Doppler US and scrotal MRI scan were performed for the differential diagnosis of possible testicular abscess and masses (Figures 1 and 2). While two patients were treated with doxycycline  mg PO and rifampicin  mg IV, 5 patients underwent streptomycin  gr IM and doxycycline  mg PO treatment over 6 weeks. 3 BEO patients with coexisting spondylitis had also sacroiliitis at the same time. These patients were treated with streptomycin  gr IM and doxycycline  mg PO combination during 2 weeks and subsequently doxycycline  mg and rifampicin  mg treatment regime was used in the following 3 months. Three patients with no skeletal involvement were treated with streptomycin  gr IM during 2 weeks and doxycycline  mg PO during 6 weeks.

While the mean hospitalization time of patients with the diagnosis of BEO and brucellosis was (4–22) days, it was (1–22) days in 28 patients who were diagnosed with brucellosis.

4. Discussion

Brucellosis which is caused by Brucella spp. and involves various organ systems, is an endemic enzootic disease. It is presented with many findings which may potentially be observed in several other diseases [1, 2]. The most frequent (2–20%) genitourinary complication of brucellosis is epididymoorchitis [3, 4]. While BEO can occur as a separate disease with no symptoms of systemic disease, it can be seen in the relapses of cases that were inadequately treated. Unilateral involvement is commonly seen in BEO. Urine analysis and culture are generally sterile [8, 10]. Yetkin et al. evaluated 186 brucellosis patients during 4 years and diagnosed 17 BEO in 186 [11]. The authors reported that 88% of BEO cases had unilateral involvement. BEO mimics testicular malignancy and/or tuberculosis with granulomatous inflammation in testis. Brucellosis, tuberculosis, infections, and trauma should be considered in the differential diagnosis of granulomatous orchitis [12, 13]. Prostate secretion and sperm cultures can be used in the diagnosis of BEO. In the previous literature, the proliferation in sperm culture of a BEO case was reported [14]. Acute scrotal pain, swelling and erythema, and unilateral involvement are characteristic findings of BEO patients reported in the previous papers [12, 15]. In the recent study, unilateral acute scrotal pain and swelling were observed in all patients.

Although the patients with brucellosis generally present with nonspecific symptoms, specific findings related to the involved organ system may also be observed. The previous literature showed that the most common complaints related to brucellosis are fever (61.2–93%), asthenia (76–97.5%), increased sweating (70.9–91%), and arthralgia (57–65%). Hepatomegaly (8.6–34.5%), splenomegaly (10.7–25.5%), lymphadenomegaly (7–11.4%), and arthritis (5.7–40%) may potentially be identified [10, 13, 1517]. Physical examination shows fever, scrotal pain/swelling, and hepatosplenomegaly in 74–100%, 91–100%, and 25–31% of patients with BEO, respectively. Changes in serum CRP, ESR, ALT, AST, leucocyte (leukopenia/leukocytosis), Hb (anemia), and platelet (thrombocytopenia) may be seen in patients with BEO [15, 1820]. In our study, all BEO patients had scrotal pain, swelling, and increased sweating. Fever, asthenia, arthralgia, dysuria, shiver, rash, weight loss, and vomiting were observed in 6, 5, 4, 4, 3, 3, 2, and 1 patients, respectively. In addition osteoarticular involvement, spondylitis, sacroiliitis, and hepatitis were determined in 4, 3, 2, and 1 patients, respectively.

In the suspicion of BEO, Brucellar agglutination tests and scrotal color Doppler US are crucial diagnostic methods for the differential diagnosis of epididymoorchitis in endemic regions of brucellosis [21]. In a previous study, 84 patients with epididymoorchitis were evaluated and BEO was determined in 14 of 84 cases (16.6%). Although brucellosis agglutination test was positive in all cases, the proliferation in blood culture was found only in 4 (28.5%) patients [7]. The proliferation rate in blood culture has been previously reported between 14% and 69% in the literature [12, 15, 20, 22]. The recent study revealed that Rose-Bengal and Wright agglutination tests were positive in all cases. While Coombs test was positive in 3 patients, no proliferation was present in blood and urine cultures.

5. Conclusion

Clinicians should be alert for BEO in the differential diagnosis of nonspecific epididymoorchitis, especially in endemic regions for brucellosis. Clinical and serological data are sufficient for the diagnosis of BEO. Conservative management combined with antibiotic therapy is adequate for the treatment.

References

  1. E. J. Young, “Brucella species,” in Mandel, Dougles and Bennett's Principles and Practise of Infectious Disease, G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., pp. 2669–2672, Elsevier Churchill Livingstone, Philadelphia, Pa, USA, 6th edition, 2005. View at: Google Scholar
  2. E. J. Young, “An overview of human brucellosis,” Clinical Infectious Diseases, vol. 21, no. 2, pp. 283–290, 1995. View at: Google Scholar
  3. J. D. Colmenero, J. M. Reguera, F. Martos et al., “Complications associated with Brucella melitensis infection: a study of 530 cases,” Medicine, vol. 75, no. 4, pp. 195–211, 1996. View at: Publisher Site | Google Scholar
  4. H. Afsar, I. Baydar, and F. Sirmatel, “Epididymo-orchitis due to brucellosis,” British Journal of Urology, vol. 72, no. 1, pp. 104–105, 1993. View at: Google Scholar
  5. Y. Tanıdır, A. Gümrah, C. Akbal, and T. Tarcan, “Brucella epidiymoorchitis as the first presenting sign of brucellosis: a case report and review of the literatüre,” Marmara Medical Journal, vol. 21, no. 1, pp. 56–60, 2008. View at: Google Scholar
  6. A. Navarro, J. Solera, M. L. Castillejos et al., “Epididymoorchitis due to Brucella mellitensis: a prospective study of 18 cases [abstract L-80],” in Programs and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego), American Society for Microbiology, Washington, DC, USA, 1988. View at: Google Scholar
  7. T. Yurdakul, U. Sert, A. Acar, G. Karalezli, and Z. Akcetin, “Epididymo-orchitis as a complication of brucellosis,” Urologia Internationalis, vol. 55, no. 3, pp. 141–142, 1995. View at: Google Scholar
  8. E. M. Reisman, L. A. Colquitt 4th, J. Childers, and G. M. Preminger, “Brucella orchitis: a rare cause of testicular enlargement,” Journal of Urology, vol. 143, no. 4, pp. 821–822, 1990. View at: Google Scholar
  9. J. L. Castillo-Soria and C. Bravo de Rueda, “Brucelosis genital. Causa rara de absceso testicular,” Archivos Españoles de Urología, vol. 47, pp. 533–536, 1994. View at: Google Scholar
  10. M. F. Özsoy, N. Koçak, and Ş. Çavuşlu, “Brusella orşiti: beşolgu sunumu,” Klimik Dergisi, vol. 11, no. 3, pp. 82–87, 1998. View at: Google Scholar
  11. M. A. Yetkin, F. S. Erdinc, C. Bulut, and N. Tülek, “Epididymoorchitis due to brucellosis in Central Anatolia, Turkey,” Urologia Internationalis, vol. 75, no. 3, pp. 235–238, 2005. View at: Publisher Site | Google Scholar
  12. M. S. Khan, M. S. Humayoon, and M. S. Al Manee, “Epididymo-orchitis and brucellosis,” British Journal of Urology, vol. 63, no. 1, pp. 87–89, 1989. View at: Google Scholar
  13. M. J. Corbel, S. S. Elberg, and O. Cosivi, Eds., Brucellosis in Humans and Animals, World Health Organization, Geneva, Switzerland, 2006.
  14. R. Öztürk, F. Sosyal, and K. Altaş, “kültüründe Brusella melitensis üretilen bir epididimo-orşit bruselloz olgusu,” Türk Mikrobiyoloji Cemiyeti dergisi, vol. 23, pp. 148–150, 1993. View at: Google Scholar
  15. A. Navarro-Martínez, J. Solera, J. Corredoira et al., “Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients,” Clinical Infectious Diseases, vol. 33, no. 12, pp. 2017–2022, 2001. View at: Publisher Site | Google Scholar
  16. A. Yüce, S. Alp-Çavuş, N. Yapar, and N. Çakır, “Bruselloz: 55 olgunundeğerlendirilmesi,” Klimik Dergisi, vol. 19, no. 1, pp. 13–17, 2006. View at: Google Scholar
  17. B. Gürsoy, S. Tekin-Koruk, F. Sirmatel, and L. Karaağaç, “Bruselloz: 140 olgunun değerlendirilmesi,” Klimik Dergisi, vol. 21, no. 3, pp. 101–104, 2008. View at: Google Scholar
  18. Y. Z. Demiroğlu, T. Turunç, H. Alışkan, S. Çolakoğlu, and H. Arslan, “Bruselloz: 151 olgunun klinik, laboratuvar ve epidemiyolojik özelliklerinin retrospektif değerlendirilmesi,” Mikrobiyoloji Bülteni, vol. 41, no. 4, pp. 517–527, 2007. View at: Google Scholar
  19. Z. A. Memish and S. Venkatesh, “Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature,” BJU International, vol. 88, no. 1, pp. 72–76, 2001. View at: Publisher Site | Google Scholar
  20. S. Cesur, Y. Çapar, P. Demir, H. Kurt, T. H. Sözen, and E. Tekeli, “Brucellaorşiti: dört olgunun incelenmesi,” Klimik Dergisi, vol. 15, no. 1, pp. 22–24, 2002. View at: Google Scholar
  21. A. Aksin and O. Mete, “Dicle Üniversitesi Tıp Fakültesi Üroloji Kliniğinde 1984–1987 yılları arasında teşhis ve tedavi edilen Brusella epididimitleri,” Türk Üroloji Dergisi, vol. 14, pp. 547–552, 1988. View at: Google Scholar
  22. J. D. Colmenero, N. L. Muñoz-Roca, P. Bermudez, A. Plata, A. Villalobos, and J. M. Reguera, “Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo-orchitis,” Diagnostic Microbiology and Infectious Disease, vol. 57, no. 4, pp. 367–372, 2007. View at: Publisher Site | Google Scholar

Copyright © 2013 Ayhan Karaköse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1840
Downloads553
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.